Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

TYCO'S $1.4 BIL. ACQUISITION OF KENDALL

This article was originally published in The Gray Sheet

Executive Summary

TYCO'S $1.4 BIL. ACQUISITION OF KENDALL will result in annual disposable medical product sales of over $730 mil. at the combined company. Under a definitive agreement announced July 14, Kendall, with $816 mil. in 1993 revenues, would be merged with Tyco's packing division to form a $1.2 bil. disposable medical and specialty products business segment. More than 80% (over $650 mil.) of Kendall's revenues come from disposable health care and related products; the product segment accounts for $80 mil. of Tyco's $400 mil. in packing division revenues.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002595

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel